- Home
- ORKA vs SWIM Comparison
ORKA vs SWIM Comparison
Compare ORKA & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- SWIM
- Stock Information
- Founded
- ORKA 2004
- SWIM 1956
- Country
- ORKA United States
- SWIM United States
- Employees
- ORKA N/A
- SWIM N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SWIM Plastic Products
- Sector
- ORKA Health Care
- SWIM Industrials
- Exchange
- ORKA Nasdaq
- SWIM Nasdaq
- Market Cap
- ORKA 866.2M
- SWIM 751.3M
- IPO Year
- ORKA N/A
- SWIM 2021
- Fundamental
- Price
- ORKA $25.47
- SWIM $6.64
- Analyst Decision
- ORKA Strong Buy
- SWIM Buy
- Analyst Count
- ORKA 4
- SWIM 4
- Target Price
- ORKA $41.33
- SWIM $5.28
- AVG Volume (30 Days)
- ORKA 66.3K
- SWIM 478.1K
- Earning Date
- ORKA 11-15-2024
- SWIM 11-05-2024
- Dividend Yield
- ORKA N/A
- SWIM N/A
- EPS Growth
- ORKA N/A
- SWIM N/A
- EPS
- ORKA N/A
- SWIM 0.10
- Revenue
- ORKA N/A
- SWIM $522,395,999.00
- Revenue This Year
- ORKA N/A
- SWIM N/A
- Revenue Next Year
- ORKA N/A
- SWIM $7.98
- P/E Ratio
- ORKA N/A
- SWIM $64.81
- Revenue Growth
- ORKA N/A
- SWIM N/A
- 52 Week Low
- ORKA $18.72
- SWIM $2.04
- 52 Week High
- ORKA $53.88
- SWIM $6.93
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- SWIM 61.36
- Support Level
- ORKA N/A
- SWIM $6.37
- Resistance Level
- ORKA N/A
- SWIM $6.93
- Average True Range (ATR)
- ORKA 0.00
- SWIM 0.31
- MACD
- ORKA 0.00
- SWIM -0.04
- Stochastic Oscillator
- ORKA 0.00
- SWIM 63.29
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.